IP Library Granted Patent US 11,278,708
Granted Patent B2
US 11,278,708 · App. 16/444,982 · Granted Mar 22, 2022

Endovascular cerebrospinal fluid shunt

Inventors: Carl Heilman (Wayland, MA); Adel M. Malek (Weston, MA)
Assignee: Tufts Medical Center, Inc.
A61M27/006A61B90/39A61B17/12168A61B17/12172A61B2090/3966A61F2/86A61F2/88A61F2/90A61F2/91A61M25/04A61M2210/0693A61M2210/12
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,278,708
App. No.
16/444,982
Granted
Mar 22, 2022
Kind
B2
Abstract

Implantable shunt devices and methods for draining cerebrospinal fluid from a patient's subarachnoid space include a shunt having opposed first and second ends, the second end being constructed to penetrate a wall of a sigmoid, transverse, straight, or sagittal sinus of the patient, a one-way valve, a hollow passageway extending between the second end and the one-way valve such that cerebrospinal fluid can be drained through the second end and out through the valve, and a mechanism coupled to the shunt and configured to anchor the shunt at a desired location proximal to the subarachnoid space.

Claims (25)

1. A method for draining cerebrospinal fluid from a patient's subarachnoid space into the venous system, the method comprising:

providing a shunt having opposed first and second ends, wherein the first and second ends are in fluid communication to enable the cerebrospinal fluid to be drained from the subarachnoid space through the first end and second end into the venous system;

endovascularly delivering the shunt to a dural venous sinus;

stabilizing the shunt against an inner wall of the dural venous sinus at a desired location proximal to the subarachnoid space;

implanting a portion of the shunt through the venous sinus wall of the patient; and

draining cerebrospinal fluid from the patient's subarachnoid space into the patient's venous system.

2. The method of claim 1 , further comprising: placing the shunt percutaneously into the venous system of the patient without the need for open surgery.

3. The method of claim 1 , further comprising draining the cerebrospinal fluid into a venous sinus lumen of the patient.

4. The method of claim 1 further comprising providing the shunt with a radiopaque material.

5. The method of claim 1 further comprising stabilizing the shunt with a collapsible member.

6. The method of claim 1 wherein a stabilizing member applies a constant outward radial force and anchors the shunt against the inner wall of the dural venous sinus at the desired location proximal to the subarachnoid space.

7. The method of claim 1 wherein the dural venous sinus is accessed via a femoral vein or jugular vein.

8. The method of claim 1 wherein the dural venous sinus comprises a sigmoid sinus.

9. An endovascularly implantable shunt device for draining cerebrospinal fluid from a patient's subarachnoid space into the venous system, the device comprising:

a shunt having opposed first and second ends;

a hollow passageway extending between the first end and the second end such that cerebrospinal fluid can be drained through the second end into the venous system;

a stabilizing mechanism coupled to the shunt and configured to anchor the shunt against an inner wall of a dural venous sinus and at a desired location proximal to the subarachnoid space.

10. The implantable shunt device of claim 9 , wherein the stabilizing mechanism comprises a stent device configured for insertion into the sinus of the patient.

11. The implantable shunt device of claim 10 , wherein the stent device includes a self-sealing port configured to have the shunt disposed therethrough.

12. The implantable shunt device of claim 11 , wherein the port includes a radiopaque ring.

13. The implantable shunt device of claim 9 , wherein at least one part of the shunt device includes a radiopaque material.

14. The implantable shunt device of claim 9 , wherein the second end of the shunt is constructed to penetrate a wall of a dural venous sinus of the patient.

15. The implantable shunt device of claim 9 , wherein the shunt device comprises a shielding mechanism coupled to the shunt and sized and configured to shield a portion of the shunt implanted in the subarachnoid space from surrounding brain parenchyma tissue.

16. The implantable shunt device of claim 15 , wherein the shielding mechanism comprises an umbrella-shaped member or a globe-shaped member.

17. The implantable shunt device of claim 16 , wherein the umbrella-shaped member or globe-shaped member includes a screen covering.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 20, 2019
From: HEILMAN, CARL; MALEK, ADEL M., DR
To: TUFTS MEDICAL CENTER, INC.
Reel/Frame 049542/0244 →
Continuity (5)
Continuation 15480543 · Apr 6, 2017
Continuation 14596335 · Jan 14, 2015
Continuation 14259614 · Apr 23, 2014
Provisional Application 61927558 · Jan 15, 2014
Related Publication 20190298977A1 · Oct 3, 2019
Cited By (2)
US 12,458,782 US 12,515,024